A network meta-analysis assessing the comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer.
Aiko Nagayama
Employment or Leadership Position - Chugai Pharma (I); Roche (I,U)
Stock Ownership - Chugai Pharma (B)
Tetsu Hayashida
No relevant relationships to disclose
Koji Okabayashi
No relevant relationships to disclose
Hiromitsu Jinno
No relevant relationships to disclose
Maiko Takahashi
No relevant relationships to disclose
Tomoko Seki
No relevant relationships to disclose
Akiko Matsumoto
No relevant relationships to disclose
Takeshi Murata
No relevant relationships to disclose
Yuko Kitagawa
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma
Other Remuneration - Chugai Pharma